Publication: Hepatic veno-occlusive disease after bone marrow transplantation
| dc.contributor.authors | Canpolat C., Basdemir D. | |
| dc.date.accessioned | 2022-03-28T14:50:10Z | |
| dc.date.accessioned | 2026-01-11T15:58:26Z | |
| dc.date.available | 2022-03-28T14:50:10Z | |
| dc.date.issued | 1996 | |
| dc.description.abstract | In the first few weeks after bone marrow transplantation, a clinical syndrome characterized by hepatomegaly, jaundice, and fluid retention develops in 10 to 70% of patients. This syndrome is due to damage to endothelial cells, sinusoids, and hepatocytes in zone 3 of the liver acinus. The proximate cause of the damage is cytoreductive therapy. This syndrome, often called veno-occlusive disease of the liver, can vary in severity from mild reversible disease to fatal disease associated with multiorgan failure. | |
| dc.identifier.issn | 10191941 | |
| dc.identifier.uri | https://hdl.handle.net/11424/255344 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Marmara Medical Journal | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Bone marrow transplantation | |
| dc.subject | Cytoreductive therapy | |
| dc.subject | Hepatic veno-occlusive disease | |
| dc.title | Hepatic veno-occlusive disease after bone marrow transplantation | |
| dc.type | review | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 95 | |
| oaire.citation.issue | 2 | |
| oaire.citation.startPage | 89 | |
| oaire.citation.title | Marmara Medical Journal | |
| oaire.citation.volume | 9 |
